Press Releases News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 194 articles
NIH Funding Cuts Hamper Ebola Preparedness and Global Health Security
How one state’s medical meal program lowered health care costs
CMS Finalizes Medicaid Work Requirement Rules, Impacting State Programs and Pharma Strategy
Novo Nordisk Reports Record Q1 Revenue Driven by Wegovy and Ozempic Demand
Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas
Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment
CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis
Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer
Opus Genetics' OPGx-LCA5 Gene Therapy Accepted Into FDA's Rare Disease Evidence Program
Takeda's TAK-881 Shows Positive Phase 2/3 Results for Primary Immunodeficiency Disease Treatment
InspireMD Receives FDA Approval for SwitchGuard Neuro Protection System CGUARDIANS III Pivotal Trial